The World Health Company on Thursday stated that 6 novel coronavirus (COVID-19) vaccines are presently seeing scientific trials.
Oxford University was the most recent entrant in a list of COVID-19 vaccine prospects released by the WHO, which currently included Moderna Inc.(NASDAQ: MRNA), Inovio Pharmaceuticals Inc.(NASDAQ: INO), and China’s Sinovac, CanSino Biological Inc., and Beijing Institute of Biological Products.
The WHO said that another 77 coronavirus vaccines were in preclinical stages, consisting of those of Novavax, Inc.(NASDAQ: NVAX), Vaxart Inc.(NASDAQ: VXRT), and Universities of Tokyo, Pittsburg, and Hong Kong.
The coronavirus vaccines are being established at a record speed as more than 2.7 million individuals have actually been infected with the virus around the world, and 190,858 have died, according to data from Johns Hopkins University.
White Home Coronavirus Job Force lead member Anthony Fauci stated that a vaccine could be prepared in a record time of 12 to 18 months since the outbreak began. Scientists at Oxford University said their vaccine might be offered at a mass scale beginning September if it is shown effective in the scientific trials.
Others, including Johnson & Johnson(NYSE: JNJ), have actually stated they might begin scientific trials of their vaccines by the end of this year.
Moderna was the first to begin medical trials in the United States in mid-March, and Inovio followed suit previously this month.
© 2020 Benzinga.com. Benzinga does not offer financial investment guidance. All rights booked.
